Airmid   Phone: (650) 368 6983
info@airmid.com
 
Welcome to Airmid Incorporated
Airmid is a privately held pharmaceutical company based in Redwood City, California. Airmid is focused on developing its novel potassium ion channel blockers as safer and more effective medicines for a variety of autoimmune diseases that are inadequately treated by current therapies. These diseases include multiple sclerosis, psoriasis, diabetes, Crohn's Disease, and rheumatoid arthritis. Airmid currently has two drug candidates in the preclinical phase of drug development.
 
 
February 2011
February 2011 AIRMID partners with Circassia to develop topical PAP-1
January 2010
Joe Sum joins AIRMID Board of Directors
July 2009
AIRMID partners with Kineta
to develop ShK peptides

more...